{"title":"A Fatal Symphony of Thrombus and Turbulence: A Case of Coronary Artery Fistula with Giant Pseudoaneurysm.","authors":"Yanqiu Zhang, Mengqi Tang, Xiaojing Ma, Yafeng He, Zhengchun Yu","doi":"10.14744/AnatolJCardiol.2026.7102","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2026.7102","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149392493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Saadet Aydın, Berkay Ekici, Murat Yalçın, Aycan Fahri Erkan, Güliz Erdem, Fatih Gümüşer, Özkan Bekler, Cengiz Şabanoğlu, Ertuğrul Okuyan, Hasan Fehmi Töre, Reviewers Aylin Yıldırır, Eleni Nakou, Lorenzo Costantini, Kadir Eren
{"title":"Aviation Medicine and Cardiovascular Assessment of Aircrew: A European Society of Cardiology-Aligned Review of Integrating International Civil Aviation Organization, European Union Aviation Safety Agency, Federal Aviation Administration, and Turkish Directorate General of Civil Aviation Aeromedical Standards.","authors":"Saadet Aydın, Berkay Ekici, Murat Yalçın, Aycan Fahri Erkan, Güliz Erdem, Fatih Gümüşer, Özkan Bekler, Cengiz Şabanoğlu, Ertuğrul Okuyan, Hasan Fehmi Töre, Reviewers Aylin Yıldırır, Eleni Nakou, Lorenzo Costantini, Kadir Eren","doi":"10.14744/AnatolJCardiol.2026.6446","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2026.6446","url":null,"abstract":"<p><p>Aeromedical certification is based on a safety-first principle: a pilot or other aircrew member must not have a medical disorder that creates an unacceptable risk of sudden or subtle incapacitation during flight. Cardiovascular disease remains one of the most important determinants of flight fitness, as it may impair consciousness, judgment, rhythm stability, exercise capacity, and hemodynamic reserve. Modern aeromedical decision-making therefore requires the integration of aviation law, operational risk, contemporary cardiology guidelines, advanced imaging, biomarkers, and long-term surveillance. The International Civil Aviation Organization (ICAO) Annex 1 provides the global licensing framework; the European Union Aviation Safety Agency (EASA) Part-MED, together with its Acceptable Means of Compliance and Guidance Material, defines detailed operational standards in Europe; and the Federal Aviation Administration (FAA) employs a protocol- and special issuance-based system for many cardiovascular and metabolic disorders. This review summarizes the aeromedical assessment of hypertension, diabetes mellitus, chronic and acute coronary syndromes, heart failure, cardiomy-opathies, arrhythmias and conduction disorders, pacemakers and implantable cardiac devices, valvular heart disease, aortic disease, congenital heart disease, venous throm-boembolism, cardiovascular pharmacotherapy, and major respiratory conditions rel-evant to flight certification. The manuscript is aligned with current European Society of Cardiology cardiovascular guidance and with the operational aeromedical principles applied by ICAO, EASA, FAA, and the Turkish Directorate General of Civil Aviation. In general, preserved ventricular function, absence of significant symptoms, low thrombo-embolic and arrhythmic risk, stable treatment, and adequate exercise capacity support certification or restricted certification. In contrast, uncontrolled hypertension, unstable diabetes, significant residual myocardial ischemia, reduced ejection fraction, malignant ventricular arrhythmias, implantable defibrillator therapy, severe valvular disease, significant aortic pathology, major congenital hemodynamic lesions, or poorly controlled sleep apnea usually preclude certification. Final decisions remain individualized and depend on license class, operational role, treatment burden, surveillance data, and the judgment of the aeromedical authority.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xinyu Che, Ao Chen, Yan Xia, Zheng Yang, Xia Shao, Binbin Yu, Danbo Lu, Jiaqi Ma, Zhangwei Chen, Juying Qian, Junbo Ge
{"title":"Circulating Quiescin Sulfhydryl Oxidase and Risk of Cardiovascular Disease: A Mendelian Randomization and Post-GWAS Analysis.","authors":"Xinyu Che, Ao Chen, Yan Xia, Zheng Yang, Xia Shao, Binbin Yu, Danbo Lu, Jiaqi Ma, Zhangwei Chen, Juying Qian, Junbo Ge","doi":"10.14744/AnatolJCardiol.2026.5239","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2026.5239","url":null,"abstract":"<p><strong>Background: </strong>To systematically evaluate the causal associations between circulating quiescin sulfhydryl oxidase (QSOX) family enzymes and cardiovascular diseases (CVDs) using Mendelian randomization (MR) and post-Genome-Wide Association Study (post-GWAS) analyses.</p><p><strong>Methods: </strong>The authors integrated protein quantitative trait locus (pQTL) data for plasma QSOX from the INTERVAL and deCODE studies with CVD GWAS summary statistics from large‑scale biobank datasets and disease‑specific consortia. Discovery MR analyses were followed by meta-analysis and independent replication. Post-GWAS annotation using the FUMA platform was performed to delineate the pQTL architecture of circulating QSOX2 and to prioritize likely causal variants. Summary-data-based Mendelian randomization (SMR) was applied to confirm direct effects of QSOX2 on CVDs and to characterize its regulatory networks at individual cis and trans pQTLs.</p><p><strong>Results: </strong>Initial pan-MR analyses suggested risk-increasing associations of circulating QSOX2 with several CVDs, but showed substantial SNP-level heterogeneity. Regional and functional annotation identified pleiotropic signals originating from distal and trans regions, and prioritized the missense variant rs12380852 as the leading causal candidate, predicted to impair QSOX2 structural stability and enzymatic activity. Notably, cis-MR and SMR analyses restricted to the QSOX2 locus revealed consistent protective effects against atrial fibrillation (AF) and heart failure (HF). Summary‑data-based Mendelian randomization on trans pQTL rs3184504 (a SH2B3 missense variant) linked SH2B3‑mediated inflammatory pathways to QSOX2 trans regulation.</p><p><strong>Conclusion: </strong>The authors' findings suggest a protective role of circulating QSOX2 in AF and HF. The prioritized causal variants and identified trans-regulatory pathways may serve as targets for future functional validation and druggable design. #Xinyu Che, Ao Chen, and Yan Xia contributed equally to this work.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Impact of Computed Tomography-Derived Body Composition on Mortality and Conduction Disturbances After Transcatheter Aortic Valve Implantation: A Sex-Specific Analysis.","authors":"Muhammed Rıdvan Ersoysal, Nazmi Kaştan, Batuhan Topcuoğlu, Bahadır Öztürk, Şükriye Uslu, Mustafa Sağan, Nermin Bayar Çakıcı, İclal Erdem Toslak, Şakir Arslan","doi":"10.14744/AnatolJCardiol.2026.6819","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2026.6819","url":null,"abstract":"<p><strong>Background: </strong>Transcatheter aortic valve implantation (TAVI) is increasingly performed for severe aortic stenosis with improving procedural success rates; however, post-procedural complications remain a significant clinical challenge. Growing evidence suggests that sarcopenia may adversely affect morbidity and mortality in this patient population.</p><p><strong>Methods: </strong>This retrospective, single-center cohort study included 171 patients undergoing elective TAVI (January 2018-February 2024). Muscle area (MA), visceral, subcutaneous (SATA), and total adipose tissue area (TATA) were measured at the L3 vertebral level from pre-procedural computed tomography angiography (CTA). Primary endpoints were all-cause and cardiac mortality; secondary endpoints were permanent cardiac conduction defect, permanent pacemaker implantation (PPI), and hospital stay.</p><p><strong>Results: </strong>The cohort comprised 95 women (55.5%) and 76 men (44.5%), median age 78.9 years, society of thoracic surgeons score 6.30 (IQR = 4.37-9.33). Over 21.8 ± 17.9 months, 43 patients (25.1%) died, including 12 cardiac deaths (7.0%). Lower MA and MA/body mass index (BMI) ratio were independently associated with cardiac mortality in men (adjusted odds ratio [OR] = 0.935, P = .016 and OR = 0.983, P = .042). Permanent cardiac conduction defect occurred in 44 patients (27.7%); lower SATA and TATA were independent predictors in women (OR = 0.990, P = .031 and OR = 0.994, P = .024). Permanent pacemaker implantation was required in 30 patients (18.6%); adipose tissue parameters were associated with PPI in women on univariate analysis but did not retain significance after multiple adjustment.</p><p><strong>Conclusion: </strong>Pre-procedural CTA-derived body composition assessment may contribute to the prediction of mortality and morbidity in TAVI patients without additional cost or radiation exposure. The association of lower MA with cardiac mortality in men, and of reduced adipose tissue with conduction disturbances in women, suggests that sex-specific body composition parameters may provide prognostic value beyond conventional risk scores.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Regayip Zehir, Elnur Alizade, Songül Usalp, Mehmet Yunus Emiroğlu, Ramazan Kargın, Nihal Özdemir, Cevat Kırma, Cihangir Kaymaz, Mehmet Muhsin Türkmen, Selçuk Pala, Şeyhmus Külahçıoğlu, Mehmet Kaan Kırali
{"title":"Early and Mid-Term Mortality After Transcatheter Aortic Valve Implantation: Five-Year Experience from the KOSUTAVI Study.","authors":"Regayip Zehir, Elnur Alizade, Songül Usalp, Mehmet Yunus Emiroğlu, Ramazan Kargın, Nihal Özdemir, Cevat Kırma, Cihangir Kaymaz, Mehmet Muhsin Türkmen, Selçuk Pala, Şeyhmus Külahçıoğlu, Mehmet Kaan Kırali","doi":"10.14744/AnatolJCardiol.2026.6567","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2026.6567","url":null,"abstract":"<p><strong>Background: </strong>Although transcatheter aortic valve implantation (TAVI) outcomes are well-documented, predictors of mortality beyond conventional surgical risk scores and valve-related factors in real-world, high-risk cohorts require further elucidation. This study aimed to identify the key determinants of 30-day and 1-year mortality following TAVI, with a focus on both patient-specific and procedure-specific complications.</p><p><strong>Methods: </strong>The KOSUTAVI study is a single-center, retrospective cohort analysis of 859 consecutive high-risk individuals with severe aortic stenosis undergoing TAVI between 2020 and 2025. Primary endpoints were 30-day and 1-year all-cause mortality. Multivariate Cox regression and Kaplan-Meier analyses were used to identify independent risk factors.</p><p><strong>Results: </strong>Mean age was 78.7 ± 6.5 years, and mean Society of Thoracic Surgeons score was 7.4 ± 2.2. The 30-day and 1-year mortality rates were 6.5% (n = 56) and 12.4% (n = 107), respectively. The 5-year all-cause mortality rate was 26.3%. In multiple Cox's analysis, chronic renal failure (hazard ratio [HR] = 7.75, P = .008, 95% CI = 1.29-16.54), presentation with cardiogenic shock (HR = 5.83, P = .028, 95% CI = 1.19-15.41), major vascular injury (HR = 22.7, P = .019, 95% CI = 1.89-45.91), and cardiac tamponade (HR = 17.9, P = .012, 95% CI = 8.13-52.62) were independently associated with 30-day mortality. While these factors were all significant in univariate analysis for 1-year mortality, they did not retain independence in the multiple model. Valve type, access route, and sex were not associated with increased mortality.</p><p><strong>Conclusion: </strong>In a high-risk TAVI population, early mortality is predominantly driven by pre-existing renal dysfunction and acute procedural complications (shock, vascular injury, and tamponade), rather than valve-specific factors. These findings underscore the critical importance of optimizing renal function before the procedure and implementing advanced vascular protection strategies to improve early survival after TAVI.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149236666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Artificial Intelligence for Peer Review in Cardiovascular Journals: Promise, Pitfalls, and a Path to Responsible Hybrid Adoption.","authors":"Uğur Canpolat, Meral Kayikcioglu","doi":"10.14744/AnatolJCardiol.2026.6615","DOIUrl":"10.14744/AnatolJCardiol.2026.6615","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13747947/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Heart Failure Risk Phenotypes Based on a 2-Dimensional Tree Structure Derived from Clinical Characteristics and Associations with Disease Prevalence and Cardiovascular Mortality in the General Population.","authors":"Yuehuan Chen, Jing Wu, Xia Zang","doi":"10.14744/AnatolJCardiol.2026.6139","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2026.6139","url":null,"abstract":"<p><strong>Background: </strong>Using the Discriminative Dimensionality Reduction Tree (DDRTree) algorithm, a 2-dimensional tree model was constructed based on conventional clinical indicators to identify heart failure (HF) risk phenotypes with different pathophysiological characteristics from the general adult population and evaluate their association with HF prevalence and cardiovascular mortality risk.</p><p><strong>Methods: </strong>A representative sample of 24 205 general US adults from the National Health and Nutrition Examination Survey 1999-2018 was analyzed. Eleven routine clinical indicators from multiple physiological dimensions were fed into the DDRTree algorithm to project each of them in a 2-dimensional space. The resulting tree structure revealed distinct HF risk phenotypes whose links to outcome HF prevalence and cardiovascular mortality risk were quantified with weighted logistic regression and Cox proportional-hazard models.</p><p><strong>Results: </strong>Discriminant Dimensionality Reduction Tree identified 3 HF risk phenotypes: normal, metabolic (characterized by upregulated glucose-metabolism markers), and inflammatory (characterized by abnormalities in inflammatory and hepatic-renal markers). After fully adjusting for confounding factors, the metabolic phenotype was significantly associated with the risk of HF compared with the normal phenotype (odds ratio [OR] = 1.96, P < .001, 95% CI: 1.47-2.62), whereas it showed no significant correlation with the risk of cardiovascular death (hazard ratio [HR] = 0.92, P = .539, 95% CI: 0.70-1.20). In contrast, the inflammatory phenotype was significantly correlated with both HF risk (OR = 3.95, P < .001, 95% CI: 2.94-5.33) and cardiovascular mortality risk (HR = 1.47, P = .002, 95% CI: 1.16-1.87).</p><p><strong>Conclusions: </strong>This study elucidates potential risk phenotypes influencing HF and cardiovascular mortality, providing new insights for precise HF risk stratification and targeted preventive interventions in the general population.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Selen Cansu Altun, Nil Özyüncü, İrem Müge Akbulut Koyuncu, Türkan Seda Tan
{"title":"Early Changes in Left Atrial Mechanics During Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Heart Failure with Preserved Ejection Fraction.","authors":"Selen Cansu Altun, Nil Özyüncü, İrem Müge Akbulut Koyuncu, Türkan Seda Tan","doi":"10.14744/AnatolJCardiol.2026.6899","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2026.6899","url":null,"abstract":"<p><strong>Background: </strong>Conventional echocardiographic improvements after sodium-glucose cotransporter-2 (SGLT2) inhibitor therapy have been reported in heart failure with preserved ejection fraction (HFpEF), but data on novel composite indices of atrial mechanics, particularly the left atrial (LA) stiffness index and the left atrioventricular coupling index (LACI), remain poorly characterized. The authors evaluated early changes in conventional diastolic parameters and atrial mechanics following initiation of SGLT2 inhibitor therapy.</p><p><strong>Methods: </strong>In this prospective, single-center observational cohort study, patients with HFpEF in sinus rhythm who were naive to SGLT2 inhibitors received empagliflozin or dapagliflozin. Clinical assessment, laboratory testing, and comprehensive echocardiography were performed at baseline and after 3 months. Echocardiographic evaluation included LA reservoir and pump strain, the LA stiffness index (E/e'/LA reservoir strain), and LACI (minimum LA volume/LV end-diastolic volume ×100).</p><p><strong>Results: </strong>Fifty patients completed follow-up (70% women; mean age, 63.9 ± 8.1 years). New York Health Association functional class improved and N-terminal pro-brain natriuretic peptide levels decreased significantly (347 [134.8-524.8] vs. 257 [161.3-427.5] pg/mL; P = .007). Left atrial volume index and E/e' decreased significantly (34.6 ± 5.5 to 32.6 ± 5.7 mL/m2 and 12.1 ± 3.2 to 9.8 ± 2.8, respectively; both P < .001). Left atrial reservoir and pump strain increased, whereas the LA stiffness index and LACI decreased significantly (all P < .001).</p><p><strong>Conclusions: </strong>In this prospective observational cohort of patients with HFpEF, initiation of SGLT2 inhibitor therapy was associated with early changes in conventional diastolic parameters and LA mechanics. Composite atrial indices, particularly the LA stiffness index and LACI, changed in parallel with established clinical and echocardiographic markers, suggesting that they may provide complementary information for monitoring early atrial remodeling during SGLT2 inhibitor therapy.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ahmet Kıvrak, Can Sezer, Uğur Canpolat, Ahmet Hakan Ateş, Selahattin Çöp, Cem Çöteli, Hikmet Yorgun, Mehmet Levent Şahiner, Ergün Barış Kaya, Necla Özer, Kudret Aytemir
{"title":"Ultrasound-Guided versus Fluoroscopy-Guided Femoral Access for Structural Heart Procedures: Outcomes From Transcatheter Aortic Valve Implantation and Left Atrial Appendage Closure.","authors":"Ahmet Kıvrak, Can Sezer, Uğur Canpolat, Ahmet Hakan Ateş, Selahattin Çöp, Cem Çöteli, Hikmet Yorgun, Mehmet Levent Şahiner, Ergün Barış Kaya, Necla Özer, Kudret Aytemir","doi":"10.14744/AnatolJCardiol.2026.6536","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2026.6536","url":null,"abstract":"<p><strong>Background: </strong>Transfemoral access is the default approach for transcatheter aortic valve implantation (TAVI) and left atrial appendage closure (LAAC). Although ultrasound (US)-guided femoral puncture improves first-pass success and reduces vascular complications in randomized trials, real-world data in contemporary structural heart interventions, including both arterial and venous large-sheath access, remain limited. The authors aimed to compare US-guided vs. conventional transfemoral access in patients undergoing TAVI and LAAC.</p><p><strong>Methods: </strong>This single-center, retrospective cohort study included 165 consecutive patients undergoing transfemoral structural procedures between January 2022 and December 2024 (93: TAVI; 72: LAAC). Ultrasound guidance was used in 57 procedures (34.5%). Arterial and venous cohorts were analyzed separately. Primary outcomes were absolute hemoglobin decrease (ΔHb) and access-site vascular complications (hematoma, pseudoaneurysm, and arteriovenous fistula). In the arterial cohort, 1 : 1 propensity score matching was performed to adjust for baseline differences.</p><p><strong>Results: </strong>Hemoglobin decline was significantly smaller with US guidance in both venous (0.80 ± 0.95 vs. 1.50 ± 1.11 g/dL; P = .009) and arterial procedures (0.58 ± 0.97 vs. 1.29 ± 1.00 g/dL; P = .002). In the venous cohort, complication rates were numerically lower but not statistically different (3.8% vs. 17.4%; P = .143). In contrast, arterial complications were significantly reduced with US guidance. After propensity matching (31 patients per group), complications occurred in 3.2% vs. 29.0% [Absolute Risk Reduction(ARR) = 25.8%, Number Need to Treat (NNT) = 4, P = .013].</p><p><strong>Conclusions: </strong>Ultrasound-guided transfemoral access was associated with reduced hemoglobin decline and fewer vascular complications, particularly in large-bore arterial procedures, supporting routine integration of real-time US guidance in structural interventions.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"HFpEF and BREATH2 score: From Prognostic Risk to Etiological Heterogeneity.","authors":"Maria Giulia Bellicini","doi":"10.14744/AnatolJCardiol.2026.7063","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2026.7063","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149163813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}